Assessment of Adverse Events and Their Ability to Discriminate Response to Anti–PD-1/PD-L1 Antibody Immunotherapy

Published 2019 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Assessment of Adverse Events and Their Ability to Discriminate Response to Anti–PD-1/PD-L1 Antibody Immunotherapy
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume -, Issue -, Pages JCO.19.01712
Publisher
American Society of Clinical Oncology (ASCO)
Online
2019-11-02
DOI
10.1200/jco.19.01712

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.